Latest News on private equities market

Australia's Domino's Pizza sued for underpaying staff, shares slide

Australia's Domino's Pizza Enterprises was hit on Tuesday by a class-action lawsuit over employee underpayment which the fast-food chain said it would defend itself against, but its shares fell more than 6% to a four-year low.



6 years ago

Trade stress hits stocks, dollar frets on Fed doves

Asian shares were haunted by trade anxiety Tuesday while the risk of more dovish talk from the Federal Reserve pushed down Treasury yields and the dollar, propelling gold to fresh six-year peaks.



6 years ago

Carrefour boss rules out exiting more countries after China deal

Carrefour boss Alexandre Bompard said he had no plans to exit other countries after the French supermarket retailer agreed to sell a majority stake in its Chinese operations to electronics retailer Suning.com.



6 years ago

Fund supermarket Allfunds bulks up with Credit Suisse deal

Spain's Allfunds Group is buying Credit Suisse's business-to-business investment fund platform InvestLab for an undisclosed sum as the investment services industry consolidates to reap the benefits of scale.



6 years ago

With job intact, Nissan's CEO pins Renault alliance on mutual respect, flags inequality risk

Nissan Motor Co Ltd on Tuesday threw cold water on hopes for a quick fix to strained relations with France's Renault SA, saying inequality between the partners could unravel their two-decade-old automaking alliance.



6 years ago

BMW's hybrid cars to switch to electric only mode in polluted cities

BMW's new hybrid cars will automatically switch off their combustion engines in heavily polluted inner city areas and use pure electric driving mode as a way to cut vehicle emissions, the carmaker said on Tuesday.



6 years ago

Trade stress, Iran tensions hits stocks, dollar frets on Fed doves

European shares were spooked by Iran tensions and trade jitters on Tuesday, while the risk of more dovish talk from the Federal Reserve inflated gold to six-year highs and stoked demand for safe-harbor currencies like the yen and Swiss franc.



6 years ago

Oil prices in balance between demand worries, U.S.-Iran tensions

Oil prices hung in the balance on Tuesday as concerns over declining crude demand were offset by risks to supply linked to new U.S. sanctions on Iran.



6 years ago

Central bankers weigh up Facebook's Libra plan

A senior member of the Swiss National Bank said he was open-minded about Facebook's cryptocurrency project, while an Italian official looked for more information as central bankers try to get to grips with the initiative.



6 years ago

AbbVie to buy Allergan in $63 billion deal

AbbVie Inc said on Tuesday it would acquire Botox-maker Allergan Plc in a cash-and-stock deal for about $63 billion.



6 years ago

Oil prices drop on demand worries, Saudi supply pledge

Oil prices inched lower on Tuesday, weighed down by concerns over declining crude demand and a Saudi pledge to offset any shortfall from countries hit by sanctions, as the market shrugged off risks to supply linked to tensions around Iran.



6 years ago

Billionaire Warren Buffett denies any tensions with his partner in troubled Kraft Heinz

Reports of tensions may have been sparked by Kraft Heinz's underperformance and because of accounting problems at the packaged goods company.

6 years ago

Firms look to attract and retain tomorrow's financial advisors

As the nation's financial advisors start to age out of the workplace, the industry is facing the fact that the number of graduates from university and college financial planning programs won't come near to replacing them.

6 years ago

Futures lower on Iran tensions, trade worries

U.S. stock futures were pulled lower by Iran tensions and trade worries on Tuesday, with investors focusing on Federal Reserve officials for more clarity on interest rates.



6 years ago

AbbVie to buy Botox-maker Allergan in $63 billion deal

Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira.



6 years ago